InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: pgsd post# 64967

Tuesday, 06/21/2016 8:53:46 AM

Tuesday, June 21, 2016 8:53:46 AM

Post# of 703801
"Who said anything about 'immediately' or 'straight away'"

You did.

#64943
"a billion dollar company with stock worth $100 a share SHORT-ly"

I should have just ignored you. Sorry. But that number comes across as a pump and that turns some people away. Clearly the stock could recover to something substantially higher than the recent highs if:

1) The Pharma Investment world feels confident that no massive changes are in store for drug pricing policy as a result of upcoming elections.
2) NWBO/LP is substantively cleared of business improprieties.
3) Substantial efficacy is observed for DCVax-L.
4) The Phase 2 combo/partner trials are initiated for Direct with substantial financing from the partners... probably paying half of trial costs. This may not be necessary for SP recovery but it might be depending on L sales and profit projections, etc..
5) A combo/partner trial for L would be great. Not sure how SP effect would compare to the same for Direct. Depends on estimated pricing and volume capability for L. Both pricing and volume capacity is greater for Direct.

But I think all that puts them at max $25 to $50 / share. I think efficacy demonstrated for Direct or Direct/Combo puts them into a larger league reaching or exceeding your $100 figure, but not "Shortly".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News